Niz Harley St Doctors nudi pristup inzulinskim pumpama za dijabetes.
Mnogi pacijenti se bore da nabave inzulinske pumpe od NHS-a, ali one su lako dostupne putem niza Harley St klinike za dijabetes.
Najnoviji dostupni napredak u isporuci inzulina je insulinska pumpa. Inzulinska pumpa se sastoji od rezervoara pumpe sličnog rezervoaru inzulinskog uloška, pumpa na baterije, i kompjuterski čip koji omogućava korisniku da kontroliše tačnu količinu insulina koja se isporučuje.
Koliko je velika insulinska pumpa?
Trenutno, pumpe na tržištu su veličine standardnog komunikacijskog bipera.
Kako radi insulinska pumpa?
Pumpa je pričvršćena na tanku plastičnu cijev (set za infuziju) koji ima mekanu kanilu (ili plastičnu iglu) na kraju kroz koji insulin prolazi. This cannula is inserted under the skin, usually on the abdomen. The cannula is changed every two days. The tubing can be disconnected from the pump while showering or swimming. The pump is used for continuous insulin delivery, 24 hours a day. The amount of insulin is programmed and is administered at a constant rate (basal rate). Often, the amount of insulin needed over the course of 24 hours varies depending on factors like exercise, activity level, and sleep.
The insulin pump allows the user to program many different basal rates to allow for variation in lifestyle. Osim toga, the user can program the pump to deliver a bolus (large dose of insulin) during meals to cover the excess demands of carbohydrate ingestion.
How common is an insulin pump?
Over 50,000 people with diabetes worldwide are using an insulinska pumpa. This number is growing dramatically as these devices become smaller and more user-friendly. Insulin pumps allow for tight blood sugar control and lifestyle flexibility while minimizing the effects of low blood sugar (hypoglycemia). At present, the pump is the closest device on the market to an artificial pancreas. More recently, newer models of the pump have been developed that do not require a tubing, in fact – the insulin delivery device is placed directly on the skin and any adjustments needed for insulin delivery are made through a PDA like device that must be kept within a 6 foot range of the insulin delivery device, and can be worn in a pocket, kept in a purse, or on a tabletop when working.
Probably the most exciting innovation in pump technology is the ability to use the pump in tandem with newer glucose sensing technology. Glucose sensors have improved dramatically in the last few years, and are an option for patients to gain further insight into their patterns of glucose response to tailor a more individual treatment regimen. The newest generation of sensors allows for a real time glucose value to be given to the patient. The implantable sensor communicates wirelessly with a pager-sized device that has a screen. The device is kept in proximity to the sensor to allow for transfer of data, kako god, it can be a few feet away and still receive transmitted information. Depending on the model, the screen displays the blood glucose reading, a thread of readings over time, and a potential rate of change in the glucose values. The sensors can be programmed to produce a “beep” if blood sugars are in a range that is selected as too high or too low. Some can provide a warning beep if the drop in blood sugar is occurring too quickly.
To take things one step further, there is one particular sensor that is new to the market that is designed to communicate directly with the insulin pump. While the pump does not yet respond directly to information from the sensor, it does “request” a response from the patient if there is a need for adjustments according to the patterns it is programmed to detect. The ultimate goal of this technology is to “close the loop” by continuously sensing what the body needs, and then responding by providing the appropriate dose of insulin. While this technology is a few more years in the making, the strides in this direction continue to grow.